Technical Analysis for MURA - Mural Oncology plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 3.38 | 0.40% | 0.01 |
MURA closed unchanged on Wednesday, November 20, 2024, on 49 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 0.40% | |
| Bollinger Band Squeeze | Range Contraction | 0.40% | |
| Outside Day | Range Expansion | 0.40% | |
| MACD Bearish Centerline Cross | Bearish | 0.40% | |
| Bollinger Band Squeeze | Range Contraction | 0.40% | |
| NR7 | Range Contraction | 0.40% | |
| Narrow Range Bar | Range Contraction | 0.40% | |
| 20 DMA Resistance | Bearish | 0.70% | |
| Fell Below 50 DMA | Bearish | 0.70% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.70% |
| Alert | Time |
|---|---|
| Hammer Candlestick Entry | 31 minutes ago |
| Rose Above Previous Day's High | 31 minutes ago |
| 50 DMA Resistance | 31 minutes ago |
| Up 1% | 31 minutes ago |
| Down 1% | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Our expertise in cytokine biology and immune cell modulation and our unmatched protein engineering will enable us to develop medicines that deliver meaningful and clinical benefits to people living with cancer. Our mission is to broaden the potential and reach of cytokine-based immunotherapies to improve the lives of patients. Mural Oncology has its registered office in Dublin, Ireland, and its primary facilities in Waltham, Mass.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Oncology Treatment Of Cancer Virotherapy Immunotherapies Cytokine Protein Engineering
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Oncology Treatment Of Cancer Virotherapy Immunotherapies Cytokine Protein Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.2499 |
| 52 Week Low | 2.88 |
| Average Volume | 85,340 |
| 200-Day Moving Average | 3.73 |
| 50-Day Moving Average | 3.41 |
| 20-Day Moving Average | 3.47 |
| 10-Day Moving Average | 3.46 |
| Average True Range | 0.17 |
| RSI (14) | 44.44 |
| ADX | 14.22 |
| +DI | 16.96 |
| -DI | 21.56 |
| Chandelier Exit (Long, 3 ATRs) | 3.23 |
| Chandelier Exit (Short, 3 ATRs) | 3.77 |
| Upper Bollinger Bands | 3.65 |
| Lower Bollinger Band | 3.30 |
| Percent B (%b) | 0.21 |
| BandWidth | 10.15 |
| MACD Line | -0.01 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0211 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.52 | ||||
| Resistance 3 (R3) | 3.51 | 3.46 | 3.50 | ||
| Resistance 2 (R2) | 3.46 | 3.42 | 3.46 | 3.49 | |
| Resistance 1 (R1) | 3.41 | 3.39 | 3.39 | 3.42 | 3.48 |
| Pivot Point | 3.36 | 3.36 | 3.34 | 3.36 | 3.36 |
| Support 1 (S1) | 3.31 | 3.32 | 3.29 | 3.32 | 3.26 |
| Support 2 (S2) | 3.26 | 3.29 | 3.26 | 3.25 | |
| Support 3 (S3) | 3.21 | 3.26 | 3.25 | ||
| Support 4 (S4) | 3.22 |
